Subscribe to Newsletter

Trends & Forecasts

Business & Regulation Business Practice

Hail the Tattletale

Does incentivizing informants deter off-label drug marketing ? Should other countries follow suit?

Business & Regulation Business Practice

Distraction Tactics

Documents reveal that Turing and Valeant both used PR to divert attention from drug price hikes

Business & Regulation Business Practice

Fighting Falsifiers

The EU takes the fight to the falsifiers with a new plan to implement packaging safety features.

Business & Regulation Business Practice

Heroes of Medicine Making

| Stephanie Vine

Power List: Last year many nominated business leaders, but did we miss any important unsung heroes?

Discovery & Development Business Practice

Design and formulation of nanomedicines

In this white paper the specific mechanisms by which nanoparticles are designed and formulated for therapeutic purposes and in which NTA has had a significant part to play is discussed.

Discovery & Development Biosimilars

Taylor Dispersion Analysis explained

Taylor Dispersion Analysis is an ultra-low volume, microcapillary flow technique for sizing and stability of biomolecules in complex solutions, and offers advantages for orthogonal and complementary biophysical characterization measurements.

Discovery & Development Business Practice

Accelerate liquid formulation development for protein biopharmaceuticals

The work presented here illustrates how Differential Scanning Calorimetry (DSC) is used in the early stages of protein characterization to rapidly provide critical data about protein stability that can be used as a guide to support and accelerate liquid formulation.

Discovery & Development Business Practice

Reverse engineering of a pharmaceutical formulation

The Morphologi G3-ID can be used to generate component-specific particle size and shape data required to aid the reverse engineering of solid oral dose formulations. Here, we provide an example case study for a powder formulation.

Discovery & Development Business Practice

Thinking Inside – and Outside – the Box

Sitting Down With... Diane Paskiet, Director of Scientific Affairs at West Pharmaceutical Services, USA.

Business & Regulation Business Practice

The Adverse Event Data Advantage

A personal experience led us to examine how adverse drug events data can be used to benefit the industry.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register